Phase 4 Schizophrenia Clinical Trials
14 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–14 of 14 trials
Recruiting
Phase 4
A Study to Evaluate the Effect of KarXT on Urological Safety
Schizophrenia
Bristol-Myers Squibb60 enrolled14 locationsNCT07221877
Recruiting
Phase 4
Anticholinergic Deprescription in Schizophrenia
SchizophreniaSchizoaffective Disorder
Deepak K. Sarpal, M.D.105 enrolled1 locationNCT06562608
Recruiting
Phase 4
CLOZAPINE Response in Biotype-1
SchizophreniaSchizoaffective DisorderBipolar 1 Disorder
University of Texas Southwestern Medical Center524 enrolled5 locationsNCT04580134
Recruiting
Phase 4
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Treatment-resistant SchizophreniaTreatment- Resistant Bipolar Disorder
Dr. Stavroula Rakitzi40 enrolled1 locationNCT07047651
Recruiting
Phase 4
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute280 enrolled7 locationsNCT05208190
Recruiting
Phase 4
Biomarkers in Clozapine-responding Schizophrenia
SchizophreniaPsychosis
Jimmi Nielsen200 enrolled1 locationNCT05316883
Recruiting
Phase 4
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
SchizophreniaMajor Depressive DisorderBipolar Disorder+2 more
Neurocrine Biosciences50 enrolled8 locationsNCT07105111
Recruiting
Phase 4
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Schizophrenia and Related DisordersEarly Treatment-Resistance
Dr. Inge Winter418 enrolled13 locationsNCT05958875
Recruiting
Phase 4
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
SchizophreniaSchizo Affective Disorder
University of Massachusetts, Worcester50 enrolled1 locationNCT06174116
Recruiting
Phase 4
"Extended" (Alternate Day) Antipsychotic Dosing
Drug TherapySchizophrenia and Related DisordersAntipsychotic Agents+1 more
Centre for Addiction and Mental Health120 enrolled1 locationNCT04478838
Recruiting
Phase 4
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
SchizophreniaBipolar I Disorder
Vanda Pharmaceuticals100 enrolled9 locationsNCT05648591
Recruiting
Phase 4
Anti-Inflammatory Challenge in Schizophrenia
Schizophrenia
Emory University20 enrolled2 locationsNCT05823532
Recruiting
Phase 4
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health30 enrolled1 locationNCT02639702
Recruiting
Phase 4
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
SchizophreniaTobacco SmokingParkinsonism+2 more
Corporal Michael J. Crescenz VA Medical Center10 enrolled1 locationNCT03495024